<< Back to Resources Home Page

SARS-CoV-2 Products – Antibodies, Assays, & Recombinant Proteins

Active Motif’s Unique Offering of Reagents for SARS-CoV-2

COVID-19 is one of the biggest public health issues in history and presents a unique challenge to the scientific research community – to develop reagents, diagnostics, and therapeutics more quickly than has ever been done.

Active Motif was one of the first companies to be involved in a key collaboration that led to the first cloning, expression, and characterization of recombinant human antibodies from patients who were infected with SARS-CoV-2, mounted an immune response, and recovered. Many of these recombinant antibodies are now available for commercial and research purposes. We also offer multiple recombinant SARS-CoV-2 proteins, including various formats of the SARS-CoV-2 Spike S1 protein, as well as many of the SARS-CoV-2 nonstructural proteins.

Recombinant SARS-CoV-2 Antibodies

In partnership with our collaborators at Fudan University, Active Motif scientists successfully performed single-cell analysis of B cells from patients who recovered from COVID-19. Cells were cloned and their antibody genes were expressed, purified, and characterized to create recombinant human antibodies. Many of these have already been published and each is available in up to gram quantities.

SARS-CoV-2 Clone 414-1 Antibody Data

Characterization of recombinant COVID-19 antibodies. Several assays were performed to characterize the recombinant human COVID-19 antibodies. The data shown here are from one representative recombinant antibody clone AM001414, Cat. No. 91361.
A.) SARS-CoV-2 Spike protein (Receptor Binding Domain, RBD) binding assay with recombinant human COVID-19 antibodies. SARS-CoV-2 Spike RBD was coated onto microtiter plates and then incubated with the indicated amount of a recombinant human COVID-19 antibody. Bound antibodies were detected with anti-human antibodies conjugated to horse radish peroxidase (HRP) and the resulting absorbance was measured at 450 nm after adding the HRP substrate. The recombinant COVID-19 antibody bound the Spike protein with high affinity. The EC50 value is indicated. B.) Inhibition of COVID-19 Spike RBD/angiotensin converting enzyme-2 (ACE2) interactions by recombinant human COVID-19 antibodies. Using a similar plate-based assay as described in A.), binding of a constant quantity of recombinant ACE2 (His-tagged) in the presence of increasing concentrations of a recombinant human COVID-19 antibody was performed. The recombinant COVID-19 antibody inhibited the interaction between the SARS-CoV-2 Spike protein and ACE2. Bound ACE2 was detected using anti-His Tag-HRP antibody. The IC50 value is indicated. C.) COVID-19 antibodies are neutralizing antibodies and can inhibit infection. Cell-based infection assays using A549 lung epithelial cell line expressing the ACE2 receptor and pseudotyped SARS-CoV-2 virus bearing the S1 spike protein show strong inhibition of viral infection by the recombinant human COVID-19 antibody. The IC50 value is indicated.

SARS-CoV-2 Recombinant Antibodies - Human Ig

  SARS-CoV-2 Spike S1 Protein Binding  
Product Name Cat. No. Applications RBD aa319-541,
Cat. No. 81343
RBD aa319-589,
Cat. No. 81344
 
SARS-CoV-2 Spike Antibody (AM001414) 91361 ELISA, Neu Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM002414) 91349 ELISA, Neu Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM004414) 91345 ELISA, WB No Yes More Info
SARS-CoV-2 Spike Antibody (AM009105) 91337 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM038105) 91339 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM043105) 91341 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM005415) 91347 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM006415) 91351 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM015553) 91377 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM002413) 91379 ELISA No Yes More Info
SARS-CoV-2 Spike Antibody (AM020553) 91381 ELISA No Yes More Info
SARS-CoV-2 Spike Antibody (AM005505) 91383 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM017553) 91387 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM018553) 91389 ELISA No Yes More Info
SARS-CoV-2 Spike Antibody (AM027553) 91391 ELISA No Yes More Info
SARS-CoV-2 Spike Antibody (AM063553) 91393 ELISA Yes Yes More Info
SARS-CoV-2 Spike IgG/IgM Antibody (AM043105) 91385 ELISA Yes Yes More Info

AbFlex® SARS-CoV-2 Recombinant Antibodies - Mouse Ig

  SARS-CoV-2 Spike S1 Protein Binding  
Product Name Cat. No. Applications RBD aa319-541,
Cat. No. 81343
RBD aa319-589,
Cat. No. 81344
 
SARS-CoV-2 Spike Antibody (AM001414) 91375 / 91376 ELISA, Neu Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM002414) 91363 / 91364 ELISA, Neu Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM004414) 91373 / 91374 ELISA, WB No Yes More Info
SARS-CoV-2 Spike Antibody (AM009105) 91365 / 91366 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM038105) 91371 / 91372 ELISA Yes Yes More Info
SARS-CoV-2 Spike Antibody (AM043105) 91367 / 91368 ELISA Yes Yes More Info

We are also looking for partners and collaborators to continue the development of these recombinant antibodies for diagnostic and/or therapeutic purposes. Contact us for more information.

Recombinant SARS-CoV-2 Proteins

Active Motif manufactures our own high-quality recombinant proteins, including SARS-CoV-2 spike S1 proteins, and a number of SARS-CoV-2 nonstructural proteins (NSPs). Each of these proteins is available in up to 1 mg quantities that are in stock and ready to ship. Contact us to inquire about bulk orders.

Recombinant SARS-CoV-2 Spike S1 protein for Antibody Binding and ACE2 Competition Assays
Recombinant SARS-CoV-2 Spike S1 protein for Antibody Binding and ACE2 Competition Assays

A) SARS-CoV-2 Spike Antibody (clone AM001414) competes with ACE2 receptor for RBD binding. SARS-CoV-2 Spike Antibody (clone AM001414) was serially diluted in the presence of 100 ng/mL biotinylated ACE2 receptor, then added to wells coated with 1 µg/mL RBD, aa319-541 for 30 min. Streptavidin-HRP was then added to detect bound ACE2 receptor. B) SARS-CoV-2 Spike Antibody (clone AM001414) blocks ACE2 receptor from binding to RBD. Serial dilutions of SARS-CoV-2 Spike Antibody (clone AM001414) was added to wells coated with 1 µg/mL RBD, aa319-541. 100 ng/mL biotinylated ACE2 receptor was then added for 30 min, followed by Streptavidin-HRP to detect bound ACE2 receptor.

Product Name Cat. No. Size  
Recombinant SARS-CoV-2 Spike protein, S1 (RBD aa319-541) 81343 100 μg More Info
Recombinant SARS-CoV-2 Spike protein, S1 (RBD aa319-589) 81344 100 μg More Info
Recombinant SARS-CoV-2 NSP1 protein 81314 / 81614 50 μg / 1 mg More Info
Recombinant SARS-CoV-2 NSP2 protein 81323 50 μg More Info
Recombinant SARS-CoV-2 NSP7 protein 81315 / 81615 50 μg / 1 mg More Info
Recombinant SARS-CoV-2 NSP8 protein 81316 / 81616 50 μg / 1 mg More Info
Recombinant SARS-CoV-2 NSP9 protein 81322 / 81622 50 μg / 1 mg More Info
Recombinant SARS-CoV-2 NSP10 protein 81317 / 81617 50 μg / 1 mg More Info
Recombinant SARS-CoV-2 NSP16 protein 81318 / 81618 50 μg / 1 mg More Info
Recombinant SARS-CoV-2 NSP10 / NSP16 complex 81319 / 81619 50 μg / 1 mg More Info
Rec. SARS-CoV-2 3C-Like Protease (NSP5), His-Tag 81320 / 81620 50 μg / 1 mg More Info
Rec. SARS-CoV-2 3C-Like Protease (NSP5), GST-Tag 81321 / 81621 50 μg / 1 mg More Info